Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionContinuum Advisory, LLC
Latest Disclosed Ownership6,008 shares
Latest Disclosed Value $ 837,335
Continuum Advisory, LLC reports 5.20% increase in ownership of GILD / Gilead Sciences, Inc.

On April 22, 2026 - Continuum Advisory, LLC filed a 13F-HR form disclosing ownership of 6,008 shares of Gilead Sciences, Inc. (CH:GILD) valued at $837,335 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 5,711 shares of Gilead Sciences, Inc.. This represents a change in shares of 5.20% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F GILEAD SCIENCES COM 375558103 6,008 297 5.20 837 19.57 0.0803
2026-02-10 2025-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 5,711 573 11.15 701 22.81 0.0702
2025-10-20 2025-09-30 13F GILEAD SCIENCES COM 375558103 5,138 209 4.24 570 4.40 0.0603
2025-08-13 2025-06-30 13F GILEAD SCIENCES COM 375558103 4,929 355 7.76 546 6.64 0.0658
2025-04-23 2025-03-31 13F GILEAD SCIENCES COM 375558103 4,574 -47 -1.02 513 20.19 0.0660
2025-02-18 2024-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 4,621 -13 -0.28 427 0.00 0.0547
2024-11-15 2024-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 4,634 -21 -0.45 427 33.54 0.0545
2024-07-19 2024-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 4,655 -442 -8.67 319 -3.04 0.0460
2024-05-13 2024-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 5,097 -8,894 -63.57 329 -70.96 0.0493
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 13,991 539 4.01 1,134 12.40 0.1613
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 13,452 -125 -0.92 1,008 -3.63 0.1616
2023-12-13 2023-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 13,577 -5,740 -29.71 1,046 -34.71 0.1664
2023-08-10 2023-06-30 13F GILEAD SCIENCES COM 375558103 13,577 -5,740 1,046 0.1664
2023-12-13 2023-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 19,317 -781 -3.89 1,603 -7.13 0.2720
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 19,317 -781 1,603 0.2720
2023-12-13 2022-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 20,098 764 3.95 1,725 44.59 0.3113
2023-02-10 2022-12-31 13F GILEAD SCIENCES COM 375558103 20,098 764 1,725 0.3113
2023-12-13 2022-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 19,334 666 3.57 1,193 3.38 0.2104
2022-11-08 2022-09-30 13F GILEAD SCIENCES COM 375558103 19,334 666 1,193 0.2104
2023-12-13 2022-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 18,668 4,187 28.91 1,154 34.34 0.2099
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 18,668 4,187 1,154 0.2099
2023-12-13 2022-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 14,481 14,481 859 0.1631
2022-05-17 2022-03-31 13F GILEAD SCIENCES COM 375558103 14,481 14,481 859 0.1631
2023-12-13 2021-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 0 -4,135 -100.00 0 -100.00
2021-11-08 2021-09-30 13F GILEAD SCIENCES COM 375558103 0 -4,135 0
2023-12-13 2021-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 4,135 -169 -3.93 285 0.71 0.0886
2021-08-17 2021-06-30 13F GILEAD SCIENCES COM 375558103 4,135 -169 285 0.0886
2021-05-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 4,304 -739 -14.65 283 -3.74 0.1179
2021-05-17 2020-12-31 13F GILEAD SCIENCES COM 375558103 5,043 0 0.00 294 -7.84 0.1338
2021-05-17 2020-09-30 13F GILEAD SCIENCES COM 375558103 5,043 -1,474 -22.62 319 -35.69 0.1746
2021-05-18 2020-06-30 13F GILEAD SCIENCES COM 375558103 6,517 1,597 32.46 496 38.94 0.3111
2021-05-18 2020-03-31 13F GILEAD SCIENCES COM 375558103 4,920 4,920 357 0.2404
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.